SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

The World Cup warning: Riots don’t start in the streets. They start online

“There’s a price where you have to say yes”: CyberArk founder on the $25 billion Palo Alto deal

"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"

“There is no better solution for Zim than the one we created”

Buzz

Most popular

Daily

Weekly

1

"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"

2

"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"

3

Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat

4

Echo: “Employees have become very good at identifying performative culture”

5

Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR

Biotech

20 stories about Biotech

Salignostics founders

Salignostics receives $1.87 million Gates Foundation grant for saliva-based HIV and pregnancy tests

Funding to accelerate non-invasive diagnostics aimed at improving access in developing regions.

מייסדי פיטולון טל זלצר ו חלים ג'ובראן

Phytolon raises $23.6 million Series B to scale natural food color production

26.05.26|Meir Orbach

Israeli biotech targets US market with fermentation-based alternatives to synthetic dyes.

Noam Solomon Immunai

AstraZeneca expands AI partnership with Immunai in deal worth up to $37.5 million

Biotech company’s immune-system modeling platform will continue supporting oncology drug development through 2027.

ארליך – קולינג קרופס

Israeli startup aims to cool the planet through agriculture

19.04.26|Hagay Gilboa, Maor Shalom Swisa

New technology developed by Cooling Crops lowers crop temperatures and restores degraded soil.

Scala Biodesign raises $16 million Series A to accelerate AI-driven drug development

31.03.26|Meir Orbach

The Israeli startup aims to cut years from protein engineering timelines.

צוות העובדים של Starget Pharma

Israeli biotech Starget secures $18 million Series A to accelerate precision cancer treatments

18.02.26|Meir Orbach

The Israeli startup is set to launch advanced trials for first-of-its-kind sarcoma treatment in collaboration with MD Anderson.

Converge Bio מפתחת פלטפורמת בינה מלאכותית לגילוי ופיתוח תרופות

Converge Bio raises $25 million Series A to accelerate AI drug discovery

The funding brings total investment to $30 million as the startup works with pharma partners on antibody design and protein optimization.

Arkin raises $100 million biotech fund focused on early clinical science

Arkin Bio Ventures III emphasizes scientific rigor amid shifting biotech markets.

וירוס וירוסים חיידק חיידקים בקטריות

BiomX collapses into court proceedings after clinical trial fails

17.12.25|Lital Dobrovitzky

Israeli biotech seeks trustee to manage asset sales amid NIS 11 million debt.

CTech Berlin Conference - Dr. Lior Shaltiel

“To get Israel to a more precise position in biotech, we need to educate our people to become better managers”

07.12.25|Zachy Hennessey

Dr. Lior Shaltiel, CEO of NurExone Biologic, speaks to CTech at Calcalist, CTech and Bank Leumi’s Mind The Tech conference in Berlin.

לייפנפלד )מימין( וכהן־סולל במשרדי NeuroKairs בתל אביב. "יכולנו לשבת כמו כל הסטארט־ אפים באחד ממגדלי ההייטק, אבל חשוב לנו לא להוציא כסף על מה שלא חובה"

The women turning a blood sample into a map of the depressed brain

27.11.25|Sophie Shulman

Tel Aviv-based NeuroKaire is using “brain-in-a-dish” models to personalize antidepressants, and is now shifting from years of research to full-scale commercialization in Israel and the U.S.

Cassidy Bio founders

Cassidy Bio raises $8M Seed round to build AI-first platform for designing genetic medicines

Founders include CRISPR, AI, and biotech veterans focused on improving safety and specificity in therapy development.

Noam Solomon Immunai

Immunai strikes $85M deal with AstraZeneca to develop new IBD drug target

AI biotech expands partnership after uncovering novel immune target with its machine learning platform.

מימין מושיק כהן קוטנר נדב בחנוף חברת אומניקס מדיקל

Omnix Medical raises $25 million Series C to tackle drug-resistant infections

Israeli biotech secures funding to complete Phase II trials for its novel antimicrobial peptide therapy.

Roche strikes $3.5 billion deal for U.S.-Israeli biotech 89bio

Founded in 2018 from Teva’s pipeline, the biotech firm is set to become a centerpiece in Roche’s obesity strategy.

טליה כהן סולל ו דפנה לייפנפלד

Israeli startup NeuroKaire launches world’s first blood test to personalize depression treatment

09.09.25|Maayan Cohen Rozen

BrightKaire uses AI and stem-cell technology to match patients with effective medications, potentially ending years of trial-and-error prescribing.

בדיקת דם מעבדה פתולוגית Pathology laboratory

Israeli biotech Senseera raises $7.1 million Seed round for liquid biopsy platform

The GEM BIOMARKERS technology aims to revolutionize diagnostics in oncology, immunology, and liver disease management.

Converge Bio founders

Converge Bio raises $5.5M in Seed funding to speed up drug discovery and development with GenAI

The Israeli startup's platform uses large language models (LLMs) trained on biological and chemical data (DNA, RNA, protein sequences, and small molecules) to help biotech and pharmaceutical companies discover and develop better-performing drugs in less time.

Noam Solomon Immunai

Immunai and Teva launch multi-tear AI collaboration for smarter drug development

The partnership will utilize Immunai’s cutting-edge immune system mapping tools to enhance precision in immunology and oncology trials.

Enzymit raises $10 million Series A for cell-free bio-production technology

The Israeli startup is building a cell-free production platform that aims to make bioproduction faster, simpler, cost-effective, and scalable.